全球牛乳腺炎市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計牛乳腺炎市場將從 2025 年的 24.2 億美元成長到 2034 年的 51.3 億美元，2026 年至 2034 年的複合年成長率為 8.69%。

由於人們對動物健康、乳牛生產力和食品安全的意識不斷提高，牛乳房炎市場正日益受到關注。乳房炎仍然是酪農業經濟損失的主要原因之一，因此對診斷、治療和預防解決方案的需求不斷成長。先進獸醫技術和畜群管理系統的日益普及正在加速市場成長。

創新重點在於快速照護現場、新型抗生素以及益生菌和疫苗等替代療法。數位化牲畜監測系統能夠實現疾病的早期發現和更有效的疾病管理。自動化擠乳系統與健康監測工具的整合進一步提高了牛的生產力和福祉。

全球乳製品消費量的成長、為減少抗生素殘留而製定的更嚴格的法規以及對永續農業的投資，都提振了市場前景。牛乳腺炎市場是動物保健領域的重要組成部分，在支持經濟發展和保障糧食安全方面發揮重要作用。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球牛乳炎市場：依產品分類

• 市場分析、洞察與預測
• 製藥
• 抗生素
• 疫苗
• 其他
• 診斷

第5章：全球牛乳房炎市場：依類型分類

• 市場分析、洞察與預測
• 臨床乳腺炎
• 亞臨床乳腺炎

第6章：全球牛乳腺炎市場：依療法分類

• 市場分析、洞察與預測
• 旱季
• 哺乳期

第7章：全球牛乳腺炎市場：依給藥途徑分類

• 市場分析、洞察與預測
• 乳房內給藥
• 全身給藥

第8章：全球牛乳房炎市場：依最終用途分類

• 市場分析、洞察與預測
• 獸醫醫院和診所
• 其他

第9章：全球牛乳房炎市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第10章 競爭格局

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第11章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Boehringer Ingelheim Animal Health
  • Zoetis
  • Merck & Co. Inc
  • Ceva
  • Elanco
  • HIPRA
  • Immucell Corporation
  • Forte Healthcare Ltd
  • Virbac
  • Heilsaa

The Bovine Mastitis Market size is expected to reach USD 5.13 Billion in 2034 from USD 2.42 Billion (2025) growing at a CAGR of 8.69% during 2026-2034.

The bovine mastitis market is gaining traction due to rising awareness of animal health, dairy productivity, and food safety. Mastitis remains a leading cause of economic losses in the dairy industry, driving demand for diagnostics, therapeutics, and preventive solutions. Increased adoption of advanced veterinary practices and herd management systems is accelerating market growth.

Innovation is focused on rapid point-of-care diagnostics, novel antibiotics, and alternative therapies such as probiotics and vaccines. Digital livestock monitoring systems are enabling early detection and better disease management. Integration of automated milking systems with health monitoring tools is further enhancing herd productivity and welfare.

The market outlook is strengthened by rising global dairy consumption, regulatory emphasis on reducing antibiotic residues, and investments in sustainable farming practices. The bovine mastitis market is positioned as a critical component of the animal health sector, supporting both economic and food security objectives.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Pharmaceuticals
• Antibiotics
• Vaccines
• Others
• Diagnostics

By Type

• Clinical Mastitis
• Sub-Clinical Mastitis

By Therapy

• Dry Period
• Lactating Period

By Route Of Administration

• Intra-Mammary
• Systemic

By End-use

• Veterinary Hospitals/Clinics
• Others

COMPANIES PROFILED

• Boehringer Ingelheim Animal Health, Zoetis, Merck Co Inc, Ceva, Elanco, HIPRA, Immucell Corporation, Forte Healthcare Ltd, Virbac, Heilsaa
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BOVINE MASTITIS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Pharmaceuticals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Antibiotics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Vaccines Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BOVINE MASTITIS MARKET: BY TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Type
• 5.2. Clinical Mastitis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Sub-Clinical Mastitis Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BOVINE MASTITIS MARKET: BY THERAPY 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Therapy
• 6.2. Dry Period Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Lactating Period Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BOVINE MASTITIS MARKET: BY ROUTE OF ADMINISTRATION 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Route Of Administration
• 7.2. Intra-Mammary Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Systemic Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL BOVINE MASTITIS MARKET: BY END-USE 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast End-use
• 8.2. Veterinary Hospitals/Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL BOVINE MASTITIS MARKET: BY REGION 2022-2034(USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Product
  • 9.2.2 By Type
  • 9.2.3 By Therapy
  • 9.2.4 By Route Of Administration
  • 9.2.5 By End-use
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Product
  • 9.3.2 By Type
  • 9.3.3 By Therapy
  • 9.3.4 By Route Of Administration
  • 9.3.5 By End-use
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Product
  • 9.4.2 By Type
  • 9.4.3 By Therapy
  • 9.4.4 By Route Of Administration
  • 9.4.5 By End-use
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Product
  • 9.5.2 By Type
  • 9.5.3 By Therapy
  • 9.5.4 By Route Of Administration
  • 9.5.5 By End-use
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 South East Asia
  • 9.5.11 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Product
  • 9.6.2 By Type
  • 9.6.3 By Therapy
  • 9.6.4 By Route Of Administration
  • 9.6.5 By End-use
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL BOVINE MASTITIS INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Boehringer Ingelheim Animal Health
  • 11.2.2 Zoetis
  • 11.2.3 Merck & Co. Inc
  • 11.2.4 Ceva
  • 11.2.5 Elanco
  • 11.2.6 HIPRA
  • 11.2.7 Immucell Corporation
  • 11.2.8 Forte Healthcare Ltd
  • 11.2.9 Virbac
  • 11.2.10 Heilsaa